secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2023-09-28T23:59:59+00:00
Accession:  0001372514-23-000132
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Kiora shareholders approve 1M-share equity plan increase and >20% issuance to Lincoln Park Capital
--------------------------------------------------------------------------------

- Amendment to 2014 Equity Incentive Plan approved, adding 1,000,000 authorized shares (1,872,064 for, 612,104 against).
- Issuance of >20% of outstanding common stock to Lincoln Park Capital Fund, LLC approved under Nasdaq Rule 5635(d) (2,051,285 for, 432,684 against).
- Adjournment proposal approved but not needed as prior two proposals passed (1,951,845 for, 526,462 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251423000132/0001372514-23-000132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251423000132/kprx-20230927.htm
  HTML page:      https://secwatch.observer/filing/0001372514-23-000132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer